top of page
Search
  • Writer's pictureA2A Pharma

A2A Pharma 2nd Quarter Update

Updated: Feb 7, 2020

Update for 2018



47 views0 comments

Recent Posts

See All

A2A co-founded biomea Fusion raises $56M

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

bottom of page